secwatch.observer — SEC 8-K summary
======================================

Issuer:     Matinas BioPharma Holdings, Inc. (MTNB)
CIK:        0001582554
Form:       8-K
Filed at:   2024-11-27T23:59:59+00:00
Accession:  0001493152-24-048036
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
LLM model:  deepseek-v4-flash:cloud@v2

Director Kathryn Penkus Corzo resigns from Matinas BioPharma board effective Nov 22, 2024
--------------------------------------------------------------------------------

- Director Kathryn Penkus Corzo resigned from Board effective Nov 22, 2024, citing other professional obligations.
- Resignation not due to any material disagreement or change in company direction.
- She also resigned from Compensation and Nominating and Corporate Governance Committees.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582554/000149315224048036/0001493152-24-048036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582554/000149315224048036/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-048036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer